Constellation Pharmaceuticals (NASDAQ:CNST)

Constellation Pharmaceuticals (NASDAQ:CNST)

Share Price
$ 9.69
-0.35 (-3.49 %)
Market Cap
$250.07 m
Proactive Investors - Run By Investors For Investors

Constellation Pharmaceuticals

Constellation Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, focuses on discovering and developing therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance. The company's lead product candidates include CPI-0610 that is in Phase II clinical trials for the treatment of patients with...

52-week High/Low: $14.040 / $4.040
Sector: Health Care, Equipment & Services
Market Cap: $250.07 m
col 3
col 4
col 5
col 6

Constellation Pharmaceuticals Timeline

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use